Content hub
World Preview
Data‑driven insight into the forces shaping the global pharmaceutical market
On-Demand
World Preview 2026 Webinar
Watch Evaluate’s experts discuss the data and insights shaping the future of the global pharmaceutical market from growth outlooks and next‑generation blockbusters to evolving pipeline dynamics, dealmaking trends, and the continued rise of China as an innovation powerhouse.
REPORT
World Preview 2026 Report
Big Drugs. Bigger Questions.
Comprehensive coverage of the pharma landscape with market analysis, deal data and forecasts to 2032.
Discover
Infographic
World Preview 2026 Infographic
A $2tn Industry at a Glance
Download the World Preview 2026 infographic to see who’s winning, what’s driving growth, and what the next six years actually look like.
Discover
China Pipelines, Western Portfolios
Two-Thirds of Pharma's Biggest Deals Now Start in China
China has shifted from generics manufacturer to the industry’s most important source of innovative assets. Chinese companies are now driving nearly 30% of the worldwide drug pipeline, backed by faster clinical trials, lower costs, and a rapidly maturing biotech ecosystem.
Western pharma has taken notice. Chinese assets are on track to make up more than two-thirds of total licensing deal value in 2026, up from just 5% five years ago. Watch our experts break down what’s driving the deals, which therapy areas China is setting the pace in, and what it means for your pipeline strategy.
Get the report (coming soon)
Explore our archive
Turning Market Insight into Tailored Commercial Strategy
The pharmaceutical market is growing steadily, but the commercial landscape is becoming more complex. Breakthrough categories such as GLP‑1s, accelerating patent expirations, pricing pressure, changing R&D economics, and rising competition from China are redefining how value is created. Understanding market‑wide trends is essential but real competitive advantage comes from understanding what they mean for your specific portfolio, assets, and investment decisions.
Evaluate helps pharmaceutical companies and investors turn market insight into tailored, actionable intelligence. Using the same trusted data and methodologies behind the World Preview, our consulting team delivers customized analyses that support confident commercial, portfolio, and investment decisions.
Ready to see how Evaluate can help you make smarter decisions?
Get in touch with our team to explore the right solutions for your business.
